MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT)

|||

Cash Flow Overview

Change in Cash
-$34,593K
Free Cash flow
-$24,253K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Proceeds from sales and maturiti...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Net loss
    • Prepaid expenses and other asset...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-22,825
38,172
-19,014
-41,721
Stock-based compensation expense
2,788
-7,757
3,554
7,581
Depreciation of property and equipment
23
-63
27
59
Deferred income tax benefit
-
-
0
-681
Accretion of discounts on investments
984
-443
196
1,117
Amortization of debt discount and costs
237
47
113
58
Loss on foreign currency exchange
-22
-38
-86
-30
Impairment loss on long-lived asset
783
709
-
-
Accounts receivable
1,676
145
524
-223
Prepaid expenses and other assets
3,722
-3,520
8
1,895
Accounts payable
-258
-5,780
3,953
640
Accrued expenses and other liabilities
1,391
-531
102
-2,064
Income tax and r&d incentive receivables
0
2,189
-10
-2,697
Net cash used in operating activities
-24,221
27,145
-11,897
-36,190
Proceeds from sales and maturities of investments
67,660
-103,967
0
143,589
Purchases of investments
289,071
-153,603
149,321
47,573
Purchases of property and equipment
32
11
0
10
Net cash used in investing activities
-221,443
49,625
-149,321
96,006
Proceeds from issuance of common stock and pre-funded warrants in direct offering, net
-
70,338
-
-
Proceeds from issuance of common stock from employee stock purchase plan
-
-114
121
170
Proceeds from exercises of stock options
-
-
33
8
Payments for tax withholding in share-based compensation
-
11
0
684
Proceeds from term loan
-
-
0
15,000
Payment for debt issuance costs
-
-
322
404
Payments of deferred offering costs
-
-209
0
298
Proceeds from issuance of common stock in at-the-market offerings, net
-89
-103,346
39,517
72,571
Proceeds from issuance of common stock and pre-funded warrants, net
281,400
-
-
-
Other financing activities
-509
-
-
-
Net cash provided by financing activities
211,071
-47,239
39,349
86,363
Net increase (decrease) in cash and cash equivalents and restricted cash
-34,593
29,531
-121,869
146,179
Cash, cash equivalents and restricted cash at beginning of period
61,278
61,278
36,968
-
Cash, cash equivalents and restricted cash at end of period
63,050
97,643
61,278
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock and...$281,400K Net cash provided byfinancing activities$211,071K (144.40%↑ Y/Y)Canceled cashflow$70,329K Net increase(decrease) in cash and cash...-$34,593K (-123.66%↓ Y/Y)Canceled cashflow$211,071K Proceeds from sales andmaturities of investments$67,660K (-52.88%↓ Y/Y)Stock-based compensationexpense$2,788K (-63.22%↓ Y/Y)Accrued expenses andother liabilities$1,391K (167.39%↑ Y/Y)Impairment loss onlong-lived asset$783K Amortization of debt discountand costs$237K (308.62%↑ Y/Y)Depreciation of property andequipment$23K (-61.02%↓ Y/Y)Loss on foreigncurrency exchange-$22K (26.67%↑ Y/Y)something is missing-$69,731K Other financingactivities-$509K Proceeds from issuance ofcommon stock in...-$89K (-100.12%↓ Y/Y)Net cash used ininvesting activities-$221,443K (-330.66%↓ Y/Y)Canceled cashflow$67,660K Net cash used inoperating activities-$24,221K (33.07%↑ Y/Y)Canceled cashflow$5,244K Purchases of investments$289,071K (507.64%↑ Y/Y)Purchases of property andequipment$32K (220.00%↑ Y/Y)Net loss-$22,825K (45.29%↑ Y/Y)Prepaid expenses andother assets$3,722K (96.41%↑ Y/Y)Accounts receivable$1,676K (851.57%↑ Y/Y)Accretion of discounts oninvestments$984K (-11.91%↓ Y/Y)Accounts payable-$258K (-140.31%↓ Y/Y)